Standard BioTools Inc.
USD0.75
+0.01 (+1.80%)
CEO
Michael Egholm
IPO Date
2011-02-10
Sector
Healthcare
Industry
Medical - Equipment & Services
Exchange
NASDAQ
Country
US
Open
$0.75
Prev. Close
$0.73
Day Low
$0.71
Day High
$0.77
52W Low
$0.70
52W High
$1.72
Market Cap
$0.29B
Volume
5.21M
| -4.4 |
| 31 Dec 2023 | FY | 47.4% | -70.2% | 50.4% | -23.1% | -0.66 | 1.45 | -2.3 |
| 31 Dec 2022 | FY | 37.8% | -194.1% | 233.3% | -48.7% | -1.26 | 4.81 | -0.5 |
| 31 Dec 2021 | FY | 53.1% | -45.4% | -62.6% | -21.5% | 1.18 | 1.45 | -5.0 |
| 31 Dec 2020 | FY | 60.3% | -38.4% | -38.1% | -16.3% | 0.69 | 2.17 | -8.2 |
| 31 Dec 2019 | FY | 54.8% | -55.3% | -42.2% | -24.5% | 0.39 | 2.93 | -3.6 |
| 31 Dec 2018 | FY | 54.6% | -52.2% | -81.8% | -19.4% | 2.39 | 3.38 | -5.8 |
| 31 Dec 2017 | FY | 51.0% | -59.4% | -195.7% | -21.1% | 6.31 | 2.83 | -3.2 |
| 31 Dec 2016 | FY | 55.9% | -72.8% | -142.7% | -24.8% | 3.66 | 3.28 | -2.8 |
| 6.4 |
| 30 Sept 2025 | Q3 | 48.5% | -177.4% | -8.7% | -6.4% | 0.07 | 4.38 | -3.6 |
| 30 Jun 2025 | Q2 | 48.8% | -153.7% | -7.9% | -6.0% | 0.07 | 5.16 | -3.4 |
| 31 Mar 2025 | Q1 | 54.6% | -128.7% | -5.7% | -4.5% | 0.07 | 6.12 | -3.9 |
| 31 Dec 2024 | Q4 | 46.9% | -72.9% | -7.2% | -5.6% | 0.07 | 5.70 | -4.8 |
| 30 Sept 2024 | Q3 | 51.7% | -59.9% | -5.5% | -4.0% | 0.18 | 3.76 | -6.7 |
| 30 Jun 2024 | Q2 | 46.1% | -203.3% | -9.0% | -6.5% | 0.18 | 3.88 | -3.5 |
| 31 Mar 2024 | Q1 | 53.1% | -70.6% | -5.6% | -4.1% | 0.16 | 4.50 | -6.2 |
| 31 Dec 2023 | Q4 | 47.4% | -70.2% | -12.1% | -6.1% | 0.60 | 1.45 | -2.2 |